US consumer group hits at FDA panels' "lack of transparency"
This article was originally published in Clinica
Executive Summary
The US consumer group Public Citizen is calling for full transparency during the open public hearing period of an FDA panel meeting to end what it calls industry's practice of stacking the public hearing with sympathetic speakers.